期刊文献+

低分子肝素钠与枸橼酸钠对重症急性肾损伤行连续性肾脏替代治疗患者抗凝及治疗效果的对比 被引量:17

Comparisons of anticoagulatory and therapeutic effects of low-molecular-weight heparin sodium versus sodium citrate in patients with severe acute kidney injury on continuous renal replacement therapy
下载PDF
导出
摘要 目的探讨局部枸橼酸钠抗凝对连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)的重症急性肾损伤(acute kidney injury,AKI)患者炎症状态的影响。方法随机抽取我院重症监护病房(intensive care unit,ICU)2018年1月至2019年12月行CRRT治疗的AKI患者枸橼酸钠组(有出血倾向或外科围手术期)和低分子肝素组(无出血倾向)各50例。枸橼酸钠组给予枸橼酸钠抗凝。低分子肝素组给予低分子肝素抗凝。比较两组治疗前后肿瘤坏死因子(tumor necrosis factor-α,TNF-α)、白细胞介素6(interleukin 6,IL-6)、降钙素原(procalcitonin,PCT)、C反应蛋白(C-reactive protein,CRP)、白细胞计数(white blood cell,WBC)、中性粒细胞与淋巴细胞比值(neutrophils lymphocytes ratio,NLR)、活化部分凝血活酶时间(activated partial thromboplastin time,APTT)、凝血酶原时间(prothrombin time,PT)、凝血酶时间(thrombin time,TT)、血清总钙、血镁、血磷、临床疗效。结果共100例/207台次纳入本研究,枸橼酸钠组50例/103台次,低分子肝素钠组50例/104台次。治疗后,枸橼酸钠组患者TNF-a、IL-6、PCT下降幅度显著高于低分子肝素组,差异均有统计学意义(P<0.05),且治疗时间越长,下降幅度越大;透析时长>24 h时枸橼酸钠组患者NLR下降幅度显著高于低分子肝素组,差异有统计学意义(P<0.05)。针对明确合并重症感染AKI的这部分患者进一步进行亚组分析,与低分子肝素组相比,枸橼酸钠组在透析6 h、12 h、24 h后,TNF-a、IL-6、PCT明显下降,且治疗时长越长,下降幅度越大,差异均有统计学意义(P<0.05)。透析24 h后WBC下降幅度和12 h、24 h后NLR下降幅度两组差异均有统计学意义(P<0.05),且枸橼酸钠组下降幅度比低分子肝素组大;透析时长>24 h时血磷、血镁、血清总钙下降幅度两组差异有统计学意义(P<0.05),血磷与血镁在枸橼酸钠组下降幅度较大,而血清总钙在低分子肝素组下降幅度较大。透析时� Objective To explore the effects of sodium citrate anticoagulation on inflammatory state in patients with severe acute renal injury(AKI)on continuous renal replacement therapy(CRRT).Methods From January 2018 to December 2019,50 AKI patients on CRRT in intensive care unit(ICU)were randomly assigned into two groups of sodium citrate(with bleeding tendency or surgical perioperative period)and low-molecular-weight heparin(without bleeding tendency).The levels of tumor necrosis factor(TNF-a),interleukin-6(IL-6),procalcitonin(PCT),C-reactive protein(CRP),white blood cell count(WBC),neutrophil to lymphocyte ratio(NLR),activated partial thromboplastin time(APTT),prothrombin time(PT),thrombin time(TT),serum total calcium,serum magnesium,blood phosphorus and clinical curative effect were compared between two groups before and after treatment.Results A total of 100 cases/207 times were recruited,including 50 cases/103 times in sodium citrate group and 50 cases/104 times in low-molecular-weight heparin group.After treatment,the declines of TNF-a,IL-6 and PCT was significantly greater in sodium citrate group than those in low-molecular-weight heparin group.And the differences were statistically significant(P<0.05).The longer treatment duration,the greater reduction.When dialysis duration was>24 h,the decline in NLR was significantly higher in regional citrate group than that in low-molecular-weight heparin group.And the difference was statistically significant(P<0.05);Further subgroup analysis was carried out for these patients with AKI patients complicated by severe infection.Compared with low-molecular-weight heparin group,the levels of TNF-a,IL-6 and PCT decreased markedly in sodium citrate group at 6/12/24 h post-dialysis.The longer treatment duration,the greater reduction.And the difference was statistically significant(P<0.05).Significant inter-group differences existed in the declines of WBC at 6/12/24 hours.And the declines of serum levels of phosphorus,magnesium and total calcium were significantly higher in sodium c
作者 穆妮热·阿卜力孜 张菁菁 穆妮热·艾尔肯 李素华 王顺 Munire Abuliz;Zhang Jing-jing;Munire Erken;Li Su-hua;Wang Shun(Department of Nephrology,First Affiliated Hospital,Xinjiang Medical University,Urumqi 830054,China)
出处 《临床肾脏病杂志》 2021年第6期472-479,共8页 Journal Of Clinical Nephrology
基金 新疆维吾尔自治区自然科学基金(2016D01C319)。
关键词 枸橼酸钠抗凝 连续性肾脏替代治疗 急性肾功能不全 Sodium citrate anticoagulation Continuous renal replacement therapy Acute kidney injury
  • 相关文献

参考文献9

二级参考文献89

  • 1孙铸兴,缪建萍,蔡晓萍,宋丹,王凉,刘斌.连续性肾脏替代治疗多脏器功能障碍综合征64例报告[J].苏州大学学报(医学版),2004,24(4):530-532. 被引量:14
  • 2许俊堂.阿加曲班临床应用的进展[J].血栓与止血学,2007,13(4):180-182. 被引量:43
  • 3Vincent J L, Sakr Y, Sprung C L, et al. Sepsis in European intensive care units : results of the soap study [ J ]. Crit Care Med, 2006,34(2) :344-353. 被引量:1
  • 4Reddy B V. Argatroban use in dialysis patients [J]. Semin DIAL, 2004,17(1) :73. 被引量:1
  • 5Zarychanski R, Doucette S, Fergusson D, et al. Early intravenous unfractionated heparin and mortality in septic shock[J]. Crit Care Med, 2008,36(11) :2973-2979. 被引量:1
  • 6Minneci P, Deans K, Natanson C, et al. Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis[ J]. Eur J Clin Microbiol Infect, 2003,22 ( 1 ) : 1-9. 被引量:1
  • 7Morabito S, Pistolesi V, Tritapepe L, et al. Regional citrate anticoagulation in CVVH:A new protocol combining citrate solution with a phosphate-containing replacement fluid[J]. Hemodial Int, 2013,17(2) :313-320. 被引量:1
  • 8Cubattoli L, Teruzzi M, Cormio M, et al. Citrate anticoagulation during CVVH in high risk bleeding patients [J]. Int J Artif Organs, 2007,30 ( 3 ) :244-252. 被引量:1
  • 9Treschan T A, Schaefer M S, Geib J, et al. Argatroban versus Lepirudin in critically ill patients (ALicia) : a randomized controlled trial [ J ]. Crit Care, 2014, 18 ( 5 ) : 588. 被引量:1
  • 10Hetzel G R, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial[ J ]. Nephrol Dial Transplant, 2011,26 ( 1 ) : 232-239. 被引量:1

共引文献88

同被引文献196

引证文献17

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部